The effect of tablet formulation and hardness on in vitro release of cephalexin from Eudragit L100 based extended release tablets

Biological and Pharmaceutical Bulletin

Volumn 25, Issue 4, 2002, Pages 541-545

  Saravanan, Muniyandy ^a   Nataraj, Kalakonda Sri ^a   Ganesh, Kettavarampalayam Swaminath ^b  

^a VELS INSTITUTE OF SCIENCE   (India)

^b Sanmar Speciality Chemicals Ltd   (India)

Author keywords

Cephalexin; Eudragit L100; Extended release tablet; Microcrystalline cellulose; Tablet hardness

Indexed keywords

CEFALEXIN; EUDRAGIT L100; MICROCRYSTALLINE CELLULOSE; POLYMER; UNCLASSIFIED DRUG; METHYLMETHACRYLATE METHACRYLIC ACID COPOLYMER; METHYLMETHACRYLATE-METHACRYLIC ACID COPOLYMER; POLYMETHACRYLIC ACID DERIVATIVE;

ARTICLE; CONTROLLED DRUG RELEASE; DRUG SOLUBILITY; DRUG STORAGE; INTERMETHOD COMPARISON; MATHEMATICAL ANALYSIS; MATHEMATICAL MODEL; PARAMETER; PHYSICAL CHEMISTRY; PREDICTION; TABLET FORMULATION; TABLET HARDNESS; CHEMISTRY; COMPRESSIVE STRENGTH; DELAYED RELEASE FORMULATION; DRUG STABILITY; HARDNESS; TABLET;

CEPHALEXIN; CHEMISTRY, PHARMACEUTICAL; COMPRESSIVE STRENGTH; DELAYED-ACTION PREPARATIONS; DRUG STABILITY; HARDNESS TESTS; POLYMETHACRYLIC ACIDS; TABLETS;

EID: 0036549727     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.25.541     Document Type: Article

References (9)

1. Thornhill T. S., Levison M. E., Johnson W. E., Kaye D., Appl. Microbiol., 17, 457-461 (1969).
2. Colin D. (ed.), "Therapeutic Drugs," 2nd ed., Churchill Livingstone, Edinburgh, United Kingdom, 1999, pp. c144-c146.
3. Shin S. C., Cho S. J., Drug Dev. Ind. Pharm., 22, 299-305 (1996).
4. Martinez-Pacheco R., Vila-Jato J. L., Concherio A., Souto C., Ramos T., Int. J. Pharmaceut., 47, 37-42 (1988).
5. Martinez-Pacheco R., Vila-Jato J. L., Souto C., Ramos T., Int. J. Pharmaceut., 32, 99-102 (1986).
6. Chang R. K., Robinson J. R., "Pharmaceutical Dosage Forms, Tablets," Vol. 3, ed. by Lieberman H. A., Lachman L., Schwartz J. B., 2nd ed., Marcel Dekker INC., New York and Basel, 1990, pp. 199-205.
7. Banker G. S., Anderson N. R., "Theory and Practice of Industrial Pharmacy," ed. by Lachman L., Lieberman H. A., Kanig J. L., 3rd ed., Varghese Publishing House, Mumbai, India, 1987, pp. 320-324.
8. Banker G. S., Anderson N. R., "Theory and Practice of Industrial Pharmacy," ed. by Lachman L., Lieberman H. A., Kanig J. L., 3rd ed., Varghese Publishing House, Mumbai, India, 1987, pp. 296-303.
9. United States Pharmacopoeia 23, United States Pharmacopoeial Convention, INC., 1995, p. 323.